查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088420

細胞增殖市場：2026-2032年全球市場預測（按產品類型、技術、細胞類型、培養系統、應用和最終用戶分類）

Cell Expansion Market by Product Type, Technology, Cell Type, Culture System, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，細胞增殖市場將成長至 568.6 億美元，複合年成長率為 15.80%。

主要市場統計數據
基準年 2025 203.6億美元
預計年份：2026年 231.8億美元
預測年份 2032 568.6億美元
複合年成長率 (%) 15.80%

細胞增殖市場概覽

細胞增殖是生物製藥生產、再生醫學、細胞和基因治療、疫苗研發、腫瘤免疫學和轉化研究的核心基礎技術。該市場的發展受到對可擴展細胞培養系統、無血清和無異質培養基、一次性生物反應器、自動化封閉式系統以及高品質試劑日益成長的需求所驅動，這些產品和服務能夠支持可重複的細胞增殖、活力、療效和污染控制。

細胞增殖領域的變革性變化

細胞增殖領域正從開放式、人工研究流程轉向封閉式、自動化、數位化監控且符合GMP規範的生產生態系。這種轉變在自體細胞治療中尤其重要，因為自體細胞治療存在患者間差異，且從採血到給藥的時間較短，因此需要嚴格的製程控制；在異體細胞治療中也同樣重要，因為異體細胞治療需要更大的批量，因此需要具有穩定細胞表現型和療效的可擴展增殖平台。

人工智慧對細胞增殖的累積影響

人工智慧（AI）正透過改進實驗設計、製程最佳化、品質預測和生產決策，成為細胞增殖領域一股切實的驅動力。人工智慧和機器學習模型能夠分析來自細胞計數、代謝物譜、影像、流式細胞技術、生物反應器感測器、電子批次記錄和環境監測系統等來源的高維度數據，從而識別出傳統統計方法難以檢測到的模式。

細胞增殖的關鍵區域性見解

隨著中國、日本、韓國、印度、新加坡和澳洲不斷拓展再生醫學研究、生物製藥生產和臨床試驗活動，亞太地區的重要性日益凸顯。中國已大幅提升其生物製藥產能，並持續積極進行免疫療法研究。日本受益於其完善的再生醫學法規結構。韓國持續投資先進的生物製藥和細胞療法基礎設施。印度正著力提升其經濟高效的生物製造能力。澳洲則憑藉其強大的醫院和研究網路，為早期臨床應用提供支援。

細胞增殖的關鍵小組見解

東協正崛起為製造和臨床研究中心，這得益於新加坡的生物程序生態系統、泰國的醫療創新計劃、馬來西亞的生命科學基礎設施、越南不斷擴大的醫療保健投資以及印尼龐大的醫療保健市場。這些趨勢使得該地區在細胞培養耗材、生物製程培訓、轉化研究以及未來細胞療法生產準備的重要性日益凸顯。海灣合作理事會（GCC）成員國正大力投資先進的醫療保健基礎設施、基因組學、精準醫療、專科醫療和本地生物製造，細胞增殖在其旨在實現醫療保健多元化和普及先進療法的長期國家戰略中發揮著至關重要的作用。

主要國家細胞增殖趨勢

美國憑藉其集中的FDA監管的細胞和基因治療研發管線、大學附屬醫療中心、生物技術資金、GMP製造地以及合約開發和生產（CDMO）能力，正引領全球細胞增殖需求。加拿大在幹細胞科學、轉化研究以及支持舉措的公私合營做出了貢獻。墨西哥和巴西正透過臨床研究、對生技藥品的需求、區域醫療保健現代化以及對本地生物製造能力的日益關注，不斷提升其重要性。

為行業領導者提供的實用建議

產業領導者應優先考慮密封、自動化且可擴展的細胞增殖平台，這些平台能夠降低擴充性風險，提高批次間一致性，支援GMP文件編制，並加強產品識別鍊和監管鏈控制。細胞療法開發商需要在研發早期階段選擇增殖技術，以避免在規模化生產、技術轉移和向監管機構提交申請時出現代價高昂的製程比較難題。

調查方法

本執行摘要基於一套系統的市場調查方法，該方法全面整合了公開的監管資料庫、臨床試驗註冊資訊、同行評審論文、政府衛生數據、行業資訊、專利趨勢、生產調查方法以及生物製程趨勢方面的專家意見。主要資訊來源通常包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、世界衛生組織 (WHO)、ClinicalTrials.gov、國家統計機構、經認可的專利資料庫、面向投資者的公開資訊以及已建立的資料庫中的科學文獻。

結論

細胞增殖市場正從研究支持轉向下一代藥物的戰略生產基地。這一成長是由細胞和基因治療管線、再生醫學、生技藥品開發、疫苗研究、免疫腫瘤學以及對可擴展、可重複且合規的細胞培養過程的需求所驅動的。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 細胞增殖市場：依產品類型分類

  • 細胞培養基
    • 含血清培養基
    • 無血清培養基
  • 試劑
    • 緩衝溶液
    • 抗生素
  • 生物反應器
    • 攪拌槽式生物反應器
    • 波浪式生物反應器
    • 中空纖維生物反應器
  • 細胞計數裝置
  • 培養容器

第8章 細胞增殖市場：依技術分類

  • 2D細胞培養
  • 3D細胞培養
    • 球體
    • 類器官
  • 利用支架進行培養
    • 水凝膠
    • 聚合物
  • 懸浮培養
  • 灌注系統

第9章 細胞增殖市場：依細胞類型分類

  • 哺乳動物細胞
    • CHO細胞
    • HEK細胞
  • 幹細胞
  • 免疫細胞
    • T細胞
    • NK細胞
    • 樹突狀細胞
  • 微生物細胞
    • 細菌
    • 東方
  • 原代細胞
    • 肝細胞
    • 纖維母細胞
    • 內皮細胞

第10章 細胞增殖市場：依培養系統分類

  • 打開
  • 閉型
  • 自動化

第11章 細胞增殖市場：依應用領域分類

  • 生物製藥生產
    • 單株抗體生產
    • 重組蛋白生產
  • 細胞和基因治療
  • 再生醫學
    • 組織工程
    • 器官再生研究
  • 研究與開發
  • 毒性測試

第12章 細胞增殖市場：依最終用戶分類

  • 學術研究機構
  • 生技公司
  • 契約製造組織
  • 製藥公司

第13章 細胞增殖市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 細胞增殖市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 細胞增殖市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Agilent Technologies Inc
  • Allogene Therapeutics Inc
  • Becton Dickinson and Company
  • Bio-Techne Corporation
  • Cellectis SA
  • CellGenix GmbH
  • Corning Incorporated
  • Cytiva Uppsala AB
  • Danaher Corporation
  • Eppendorf SE
  • FUJIFILM Irvine Scientific Inc
  • GE HealthCare Technologies Inc
  • Getinge AB
  • HiMedia Laboratories Pvt Ltd
  • Kite Pharma Inc
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • PBS Biotech Inc
  • Promab Biotechnologies Inc
  • PromoCell GmbH
  • Repligen Corporation
  • Sartorius AG
  • STEMCELL Technologies Inc
  • Takara Bio Inc
  • Takara Bio USA Holdings Inc
  • Terumo Corporation
  • Thermo Fisher Scientific Inc
  • WuXi AppTec Co Ltd
Product Code: MRR-034230D3E639

The Cell Expansion Market is projected to grow by USD 56.86 billion at a CAGR of 15.80% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.36 billion
Estimated Year [2026] USD 23.18 billion
Forecast Year [2032] USD 56.86 billion
CAGR (%) 15.80%

Cell Expansion Market Introduction

Cell expansion is a core enabling technology for biopharmaceutical manufacturing, regenerative medicine, cell and gene therapy, vaccine development, immuno-oncology, and translational research. The market is shaped by rising demand for scalable cell culture systems, serum-free and xeno-free media, single-use bioreactors, closed-system automation, and high-quality reagents that support reproducible cell growth, viability, potency, and contamination control.

Publicly observable demand signals remain strong: regulatory activity for cell and gene therapies continues to expand across FDA and EMA pathways, ClinicalTrials.gov lists thousands of active cell therapy-related studies globally, and biomanufacturing investment remains closely tied to advanced therapy medicinal products. As developers move from laboratory-scale workflows to clinical and commercial manufacturing, cell expansion solutions are increasingly evaluated on sterility assurance, process scalability, cost per dose, regulatory traceability, chain-of-identity control, and compatibility with good manufacturing practice standards.

Transformative Shifts in the Cell Expansion Landscape

The cell expansion landscape is shifting from open, manual, research-grade workflows toward closed, automated, digitally monitored, and GMP-aligned manufacturing ecosystems. This transition is especially important for autologous cell therapies, where patient-specific variability and short vein-to-vein timelines require robust process control, and for allogeneic approaches, where larger batch sizes demand scalable expansion platforms with consistent cell phenotype and potency.

Suppliers are differentiating through integrated portfolios that combine media, growth factors, cultureware, bioreactors, sensors, analytics, cell separation tools, and cryopreservation solutions. The industry is also moving toward serum-free, xeno-free, and chemically defined media to reduce variability and support regulatory acceptance. At the same time, capacity constraints, skilled labor shortages, cold-chain complexity, and quality-control requirements are accelerating adoption of modular manufacturing, single-use assemblies, automated cell processing systems, and standardized digital batch documentation.

Cumulative Impact of Artificial Intelligence on Cell Expansion

Artificial intelligence is becoming a practical accelerator for cell expansion by improving experimental design, process optimization, quality prediction, and manufacturing decision-making. AI and machine learning models can analyze high-dimensional data from cell counts, metabolite profiles, imaging, flow cytometry, bioreactor sensors, electronic batch records, and environmental monitoring systems to identify patterns that are difficult to detect through conventional statistical methods.

The strongest near-term impact is in predictive process control, anomaly detection, media optimization, donor variability assessment, and release testing support. AI-enabled image analysis can improve consistency in confluence assessment and morphology tracking, while digital twins can help manufacturers simulate scale-up scenarios before committing costly GMP resources. However, adoption depends on validated data integrity, explainable models, cybersecurity, audit-ready documentation, and alignment with regulatory expectations for computerized systems, model lifecycle management, and quality-by-design manufacturing.

Key Regional Insights for Cell Expansion

Asia-Pacific is gaining importance as China, Japan, South Korea, India, Singapore, and Australia expand regenerative medicine research, biologics manufacturing, and clinical trial activity. China has built substantial biopharma capacity and remains highly active in immune cell therapy research; Japan benefits from an established regenerative medicine regulatory framework; South Korea continues to invest in advanced biologics and cell therapy infrastructure; India is strengthening cost-efficient biomanufacturing capabilities; and Australia supports early-phase clinical translation through strong hospital and research networks.

North America remains a leading hub because of the concentration of FDA-regulated clinical development, venture funding, academic medical centers, contract development and manufacturing organizations, and commercial cell therapy launches in the United States, with Canada contributing recognized stem cell science, translational research, and biomanufacturing initiatives. Latin America is developing gradually, led by Brazil and Mexico, where public health demand, clinical research networks, improving biologics capacity, and university-led biomedical programs support future adoption of cell expansion technologies.

Europe benefits from EMA oversight, advanced therapy medicinal product expertise, and strong clusters in Germany, France, the United Kingdom, Italy, Spain, the Netherlands, Belgium, Switzerland, and the Nordics. The Middle East is investing in biomedical innovation, precision medicine, specialty hospitals, genomics, and local production ambitions, particularly in the Gulf. Africa is earlier-stage but strategically relevant as vaccine manufacturing programs, academic partnerships, regional bioprocessing initiatives, and public health-focused biotechnology capacity build the foundation for long-term cell culture and cell expansion adoption.

Key Group Insights for Cell Expansion

ASEAN is emerging as a manufacturing and clinical research corridor, supported by Singapore's bioprocessing ecosystem, Thailand's medical innovation programs, Malaysia's life sciences base, Vietnam's expanding healthcare investment, and Indonesia's healthcare scale. These dynamics make the region increasingly relevant for cell culture consumables, bioprocess training, translational research, and future cell therapy manufacturing readiness. The GCC is investing in advanced healthcare infrastructure, genomics, precision medicine, specialty care, and local biomanufacturing ambitions, making cell expansion relevant to long-term national strategies focused on healthcare diversification and advanced therapeutics access.

The European Union provides a harmonized regulatory environment for advanced therapy medicinal products, while national centers of excellence support process development, quality systems, and GMP translation. BRICS countries represent a significant demand base because of large patient populations, expanding biologics manufacturing, academic research activity, and public-sector interest in local production. G7 markets continue to lead in funding intensity, regulatory maturity, intellectual property generation, clinical trial infrastructure, and commercial adoption of advanced therapies. NATO countries overlap heavily with mature biopharma economies, where supply chain resilience, sterile manufacturing, critical reagent access, and domestic bioproduction capacity are increasingly strategic priorities.

Key Country Insights for Cell Expansion

The United States leads global cell expansion demand through its concentration of FDA-regulated cell and gene therapy pipelines, academic medical centers, biotech funding, GMP manufacturing sites, and contract development and manufacturing capacity. Canada contributes recognized stem cell science, translational research, and supportive public-private biomanufacturing initiatives. Mexico and Brazil are building relevance through clinical research, biologics demand, regional healthcare modernization, and growing interest in local biomanufacturing capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced clinical research, hospital networks, regulatory experience, and GMP manufacturing expertise, while Russia maintains scientific capacity but faces constraints linked to sanctions, technology access, supply chain limitations, and capital flows. China is one of the most active countries in cell therapy clinical development and manufacturing scale-up. India is advancing through cost-efficient biomanufacturing, stem cell research, vaccine and biologics expertise, and a growing biotech base. Japan benefits from regenerative medicine policy experience and strong translational research; Australia offers robust clinical trial infrastructure and biomedical research quality; and South Korea is a leading Asian hub for biologics, biosimilars, regenerative medicine, and cell therapy manufacturing.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize closed, automated, and scalable cell expansion platforms that reduce contamination risk, improve batch consistency, support GMP documentation, and enable stronger chain-of-identity and chain-of-custody control. Developers of cell therapies should select expansion technologies early in development to avoid costly process comparability challenges during scale-up, technology transfer, and regulatory submission.

Manufacturers should invest in serum-free, xeno-free, and chemically defined media; real-time analytics; validated digital systems; and quality-by-design frameworks to improve reproducibility and reduce cost of goods. Partnerships with contract manufacturers, academic medical centers, automation vendors, reagent suppliers, and analytics providers can shorten development timelines. Leaders should also build resilient supply chains for critical reagents, single-use components, cytokines, growth factors, cultureware, and consumables, while maintaining qualified dual sourcing where quality, continuity, and regulatory requirements allow.

Research Methodology

This executive summary is based on a structured market research methodology that triangulates public regulatory databases, clinical trial registries, peer-reviewed publications, government health data, trade information, patent activity, manufacturing announcements, and expert interpretation of bioprocessing trends. Key sources typically include FDA, EMA, WHO, ClinicalTrials.gov, national statistics agencies, recognized patent databases, public investor disclosures, and scientific literature indexed in established repositories.

The methodology evaluates demand drivers, technology adoption, manufacturing constraints, regulatory dynamics, regional capacity, supply chain resilience, and competitive positioning without relying on unsupported projections. Findings are validated through cross-source comparison to reduce dependence on single-point evidence. Market interpretation emphasizes verified developments, observable investment patterns, approved therapy trends, clinical pipeline activity, regulatory requirements, and practical manufacturing needs across research, clinical, and commercial cell expansion workflows.

Conclusion

The cell expansion market is transitioning from a research-support segment into a strategic manufacturing foundation for next-generation medicine. Growth is being driven by cell and gene therapy pipelines, regenerative medicine, biologics development, vaccine research, immuno-oncology, and the need for scalable, reproducible, and compliant cell culture processes.

Competitive advantage will increasingly depend on automation, closed processing, AI-enabled analytics, defined media systems, validated quality controls, and regional manufacturing resilience. Organizations that align technology selection with regulatory expectations, clinical scalability, sterility assurance, and cost-of-goods discipline will be best positioned to capture value as cell-based therapies move from specialized treatment centers toward broader commercial access.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Expansion Market, by Product Type

  • 7.1. Cell Culture Media
    • 7.1.1. Serum Based Media
    • 7.1.2. Serum Free Media
  • 7.2. Reagents
    • 7.2.1. Buffers
    • 7.2.2. Antibiotics
  • 7.3. Bioreactors
    • 7.3.1. Stirred Tank Bioreactors
    • 7.3.2. Wave Bioreactors
    • 7.3.3. Hollow Fiber Bioreactors
  • 7.4. Cell Counters
  • 7.5. Culture Vessels

8. Cell Expansion Market, by Technology

  • 8.1. 2D Cell Culture
  • 8.2. 3D Cell Culture
    • 8.2.1. Spheroid
    • 8.2.2. Organoid
  • 8.3. Scaffold based Culture
    • 8.3.1. Hydrogel
    • 8.3.2. Polymer
  • 8.4. Suspension Culture
  • 8.5. Perfusion Systems

9. Cell Expansion Market, by Cell Type

  • 9.1. Mammalian Cells
    • 9.1.1. CHO Cells
    • 9.1.2. HEK Cells
  • 9.2. Stem Cells
  • 9.3. Immune Cells
    • 9.3.1. T Cells
    • 9.3.2. NK Cells
    • 9.3.3. Dendritic Cells
  • 9.4. Microbial Cells
    • 9.4.1. Bacteria
    • 9.4.2. Yeast
  • 9.5. Primary Cells
    • 9.5.1. Hepatocytes
    • 9.5.2. Fibroblasts
    • 9.5.3. Endothelial

10. Cell Expansion Market, by Culture System

  • 10.1. Open
  • 10.2. Closed
  • 10.3. Automated

11. Cell Expansion Market, by Application

  • 11.1. Biopharmaceutical Production
    • 11.1.1. Monoclonal Antibody Production
    • 11.1.2. Recombinant Protein Production
  • 11.2. Cell & Gene Therapy
  • 11.3. Regenerative Medicine
    • 11.3.1. Tissue Engineering
    • 11.3.2. Organ Regeneration Research
  • 11.4. Research & Development
  • 11.5. Toxicology Testing

12. Cell Expansion Market, by End User

  • 12.1. Academic Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Contract Manufacturing Organizations
  • 12.4. Pharmaceutical Companies

13. Cell Expansion Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Cell Expansion Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cell Expansion Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Agilent Technologies Inc
  • 17.2. Allogene Therapeutics Inc
  • 17.3. Becton Dickinson and Company
  • 17.4. Bio-Techne Corporation
  • 17.5. Cellectis SA
  • 17.6. CellGenix GmbH
  • 17.7. Corning Incorporated
  • 17.8. Cytiva Uppsala AB
  • 17.9. Danaher Corporation
  • 17.10. Eppendorf SE
  • 17.11. FUJIFILM Irvine Scientific Inc
  • 17.12. GE HealthCare Technologies Inc
  • 17.13. Getinge AB
  • 17.14. HiMedia Laboratories Pvt Ltd
  • 17.15. Kite Pharma Inc
  • 17.16. Lonza Group AG
  • 17.17. Merck KGaA
  • 17.18. Miltenyi Biotec GmbH
  • 17.19. PBS Biotech Inc
  • 17.20. Promab Biotechnologies Inc
  • 17.21. PromoCell GmbH
  • 17.22. Repligen Corporation
  • 17.23. Sartorius AG
  • 17.24. STEMCELL Technologies Inc
  • 17.25. Takara Bio Inc
  • 17.26. Takara Bio USA Holdings Inc
  • 17.27. Terumo Corporation
  • 17.28. Thermo Fisher Scientific Inc
  • 17.29. WuXi AppTec Co Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL EXPANSION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CELL EXPANSION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CELL EXPANSION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CELL EXPANSION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CELL EXPANSION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CELL EXPANSION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CELL EXPANSION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CELL EXPANSION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SERUM BASED MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SERUM BASED MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SERUM BASED MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SERUM FREE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SERUM FREE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SERUM FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUFFERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BUFFERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUFFERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STIRRED TANK BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STIRRED TANK BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STIRRED TANK BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WAVE BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOLLOW FIBER BIOREACTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOLLOW FIBER BIOREACTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOLLOW FIBER BIOREACTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL COUNTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CELL COUNTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL COUNTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CULTURE VESSELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CULTURE VESSELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CULTURE VESSELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 2D CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 2D CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 2D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL 3D CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL 3D CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPHEROID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPHEROID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPHEROID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ORGANOID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ORGANOID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ORGANOID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SCAFFOLD BASED CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SCAFFOLD BASED CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SCAFFOLD BASED CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HYDROGEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HYDROGEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HYDROGEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERFUSION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CHO CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CHO CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CHO CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEK CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEK CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEK CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IMMUNE CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMMUNE CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IMMUNE CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL T CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL T CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL T CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NK CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NK CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NK CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DENDRITIC CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DENDRITIC CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DENDRITIC CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MICROBIAL CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MICROBIAL CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MICROBIAL CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL YEAST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL YEAST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL YEAST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PRIMARY CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HEPATOCYTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEPATOCYTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEPATOCYTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FIBROBLASTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FIBROBLASTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FIBROBLASTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ENDOTHELIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOTHELIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ENDOTHELIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OPEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL OPEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL OPEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CLOSED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CLOSED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CLOSED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOPHARMACEUTICAL PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPHARMACEUTICAL PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOPHARMACEUTICAL PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL RECOMBINANT PROTEIN PRODUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CELL & GENE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ORGAN REGENERATION RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ORGAN REGENERATION RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ORGAN REGENERATION RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL CELL EXPANSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. GCC CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. GCC CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. GCC CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 295. GCC CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 296. GCC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 297. GCC CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. GCC CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 300. GCC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. GCC CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 302. GCC CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 303. GCC CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 304. GCC CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 305. GCC CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 306. GCC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. GCC CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 308. GCC CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 309. GCC CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 339. BRICS CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 340. BRICS CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 341. BRICS CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 342. BRICS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. BRICS CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 344. BRICS CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 345. BRICS CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 346. G7 CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. G7 CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 348. G7 CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 349. G7 CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 350. G7 CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 351. G7 CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 352. G7 CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 353. G7 CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 354. G7 CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. G7 CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 356. G7 CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 357. G7 CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 358. G7 CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 359. G7 CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 360. G7 CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 361. G7 CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 362. G7 CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 363. G7 CELL EXPANSION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 364. NATO CELL EXPANSION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 365. NATO CELL EXPANSION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 366. NATO CELL EXPANSION MARKET SIZE, BY CELL CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 367. NATO CELL EXPANSION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 368. NATO CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2032 (USD MILLION)
  • TABLE 369. NATO CELL EXPANSION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 370. NATO CELL EXPANSION MARKET SIZE, BY 3D CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 371. NATO CELL EXPANSION MARKET SIZE, BY SCAFFOLD BASED CULTURE, 2018-2032 (USD MILLION)
  • TABLE 372. NATO CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 373. NATO CELL EXPANSION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2032 (USD MILLION)
  • TABLE 374. NATO CELL EXPANSION MARKET SIZE, BY IMMUNE CELLS, 2018-2032 (USD MILLION)
  • TABLE 375. NATO CELL EXPANSION MARKET SIZE, BY MICROBIAL CELLS, 2018-2032 (USD MILLION)
  • TABLE 376. NATO CELL EXPANSION MARKET SIZE, BY PRIMARY CELLS, 2018-2032 (USD MILLION)
  • TABLE 377. NATO CELL EXPANSION MARKET SIZE, BY CULTURE SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 378. NATO CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 379. NATO CELL EXPANSION MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 380.